Trial Profile
Comparison of efficacy of Depo-subQ Provera 104 and Lupron in patients with endometriosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Medroxyprogesterone (Primary)
- Indications Endometriosis; Pain
- Focus Therapeutic Use
- 11 Dec 2015 New trial record
- 29 Mar 2005 According to Pfizer media release, the US FDA approved Depo-subQ Provera 104 for the management of pain associated with endometriosis.